FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,547,086 | +34.5% | 11,609,704 | 0.0% | 1.02% | +40.4% |
Q2 2023 | $38,312,023 | +15.8% | 11,609,704 | 0.0% | 0.72% | -3.5% |
Q1 2023 | $33,087,656 | -52.2% | 11,609,704 | +22.1% | 0.75% | -46.7% |
Q4 2022 | $69,203,134 | +22.2% | 9,505,925 | +35.8% | 1.40% | +16.2% |
Q3 2022 | $56,630,000 | – | 7,000,000 | – | 1.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 2,343,154 | $24,556,000 | 11.69% |
TRV GP III, LLC | 5,962,202 | $62,484,000 | 10.91% |
ACUTA CAPITAL PARTNERS, LLC | 604,074 | $6,331,000 | 2.53% |
COWEN AND COMPANY, LLC | 1,319,887 | $13,832,000 | 0.72% |
Altium Capital Management LP | 213,533 | $2,238,000 | 0.52% |
RTW INVESTMENTS, LP | 3,205,291 | $33,591,000 | 0.51% |
Parkman Healthcare Partners LLC | 146,389 | $1,534,000 | 0.34% |
Casdin Capital, LLC | 1,154,476 | $12,099,000 | 0.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,627,444 | $17,056,000 | 0.26% |
HARVARD MANAGEMENT CO INC | 410,714 | $4,304,000 | 0.25% |